{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:58:27Z","timestamp":1793051907733,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jbspin.2021.105129","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T11:46:28Z","timestamp":1611143188000},"page":"105129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Bone and primary hyperparathyroidism"],"prefix":"10.1016","volume":"89","author":[{"given":"Catherine","family":"Cormier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Koumakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2021.105129_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2021.105129_bib0010","first-page":"N12","article-title":"The epidemiology of primary hyperparathyroidism in North America","volume":"17","author":"Meltom","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2021.105129_bib0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2021.105129_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2021.105129_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients. The parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"73","author":"Yu","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jbspin.2021.105129_bib0030","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1210\/jc.2018-02456","article-title":"Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial","volume":"104","author":"Ejlsmark-Svensson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0035","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0040","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0045","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0050","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0055","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2021.105129_bib0060","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0065","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0070","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0075","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients with Primary HPT (the SIPH Study)","volume":"32","author":"Lundstam","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2021.105129_bib0080","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s00198-016-3715-3","article-title":"Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis","volume":"27","author":"Singh Ospina","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2021.105129_bib0085","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2021.105129_bib0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1196\/annals.1402.012","article-title":"Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism: a prospective study","volume":"1117","author":"Lumachi","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jbspin.2021.105129_bib0095","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0100","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00198-014-2689-2","article-title":"Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism","volume":"25","author":"Koumakis","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2021.105129_bib0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.surg.2018.04.065","article-title":"Bone mineral density changes after parathyroidectomy are dependent on biochemical profile","volume":"165","author":"Lee","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.jbspin.2021.105129_bib0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00423-018-1659-0","article-title":"Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?","volume":"403","author":"Traini","year":"2018","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.jbspin.2021.105129_bib0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/a-0850-8679","article-title":"Trabecular Bone Score, Bone Mineral Density and Bone Markers in Patients with Primary Hyperparathyroidism 2 Years after Parathyroidectomy","volume":"51","author":"Miguel","year":"2019","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jbspin.2021.105129_bib0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.surg.2016.06.062","article-title":"Parathyroidectomy for asymptomatic primary hyperparathyroidism. A revised cost\u2013effectiveness analysis incorporating fracture risk, reduction surgery","volume":"161","author":"Zanocco","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.jbspin.2021.105129_bib0130","first-page":"173","article-title":"High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria","volume":"28","author":"Glendenning","year":"1998","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.jbspin.2021.105129_bib0135","first-page":"297","article-title":"Ionized calcium: it's significance and clinical usefulness","volume":"21","author":"Forman","year":"1991","journal-title":"Ann Clin Lab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0140","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2012-4197","article-title":"Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels","volume":"98","author":"Lim","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jbspin.2018.10.001","article-title":"Genetic hypercalcemia","volume":"86","author":"Cormier","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2021.105129_bib0150","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0155","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2009-2791","article-title":"The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma","volume":"95","author":"Cavalier","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40618-016-0553-2","article-title":"How the reference values for serum parathyroid hormone concentration are (or should be) established?","volume":"40","author":"Souberbielle","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jbspin.2021.105129_bib0165","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1210\/jc.2017-02773","article-title":"Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia","volume":"103","author":"Bertocchio","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsbmb.2010.03.077","article-title":"Vitamin D and primary hyperparathyroidism (PHPT)","volume":"121","author":"Souberbielle","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jbspin.2021.105129_bib0175","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J Clin Endocriol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/EJE-07-0132","article-title":"Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism","volume":"157","author":"Titon","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jbspin.2021.105129_bib0185","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/jc.2011-2639","article-title":"Primary hyperparathyroidism and celiac disease: a population-based cohort study","volume":"97","author":"Ludvigsson JF1","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0190","doi-asserted-by":"crossref","first-page":"L27","DOI":"10.1210\/jc.2014-4065","article-title":"Letter to the editor: Thiazides are not inducers of PTH secretion: a comment on normocalcemic hyperparathyroidism","volume":"100","author":"Yacobi-Bach M1","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/a-0859-1020","article-title":"Normocalcemic primary hyperparathyroidism in adults without a history of nephrolithiasis or fractures: a prospective study","volume":"51","author":"Rosario","year":"2019","journal-title":"Horm Metab RES"},{"key":"10.1016\/j.jbspin.2021.105129_bib0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","article-title":"Management of normocalcemic primary hyperparathyroidism","volume":"32","author":"Cusano","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0205","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjsurg.2019.10.032","article-title":"Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more agressive than the hypercalcemic form?","volume":"219","author":"Gomez-Ramirez","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.jbspin.2021.105129_bib0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12872-019-1093-4","article-title":"Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"19","author":"Beysel","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jbspin.2021.105129_bib0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.surg.2019.06.043","article-title":"Normocalcemic hyperparathyroidism: A collaborative endocrine surgery quality improvement program analysis","volume":"167","author":"Pandian","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.jbspin.2021.105129_bib0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.surg.2016.08.054","article-title":"Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism","volume":"161","author":"Lim","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.jbspin.2021.105129_bib0225","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/0194599818793879","article-title":"Surgical Management of Normocalcemic Primary Hyperparathyroidism and the Impact of Intraoperative Parathyroid Hormone Testing on Outcome","volume":"159","author":"Trinh","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jbspin.2021.105129_bib0230","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40618-018-0931-z","article-title":"PETC\/CT with 18F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism","volume":"42","author":"Bossert","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jbspin.2021.105129_bib0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00774-011-0344-y","article-title":"Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism","volume":"30","author":"Campenni","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0240","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12893-019-0638-x","article-title":"Case report: a camouflaged parathyroid carcinoma with initial misdiagnosis","volume":"19","author":"Cao","year":"2019","journal-title":"BMC Surg"},{"key":"10.1016\/j.jbspin.2021.105129_bib0245","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00198-014-3000-2","article-title":"Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism","volume":"26","author":"Cesareo","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2021.105129_bib0250","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcma.2012.06.012","article-title":"Primary hyperparathyroidism in children and adolescents","volume":"75","author":"Roizen","year":"2012","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jbspin.2021.105129_bib0255","doi-asserted-by":"crossref","DOI":"10.1210\/js.2019-00316","article-title":"Clinical presentation of primary hyperparathyroidism in older adults","volume":"3","author":"Castellano","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jbspin.2021.105129_bib0260","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamainternmed.2019.1747","article-title":"Diagnosis and management of primary hyperparathyroidism across the veterans affairs health care system","volume":"179","author":"Alore","year":"2019","journal-title":"JAMA Int Med"},{"key":"10.1016\/j.jbspin.2021.105129_bib0265","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00268-019-05280-9","article-title":"Parathyroidectomy is safe in elderly patient: A national surgical quality improvement program study","volume":"44","author":"Khokar","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.jbspin.2021.105129_bib0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40520-016-0666-7","article-title":"Parathyroidectomy for primary hyperparathyroidism in the elderly: experience of a single endocrine surgery center","volume":"29","author":"Cal\u00f2","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jbspin.2021.105129_bib0275","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1210\/jc.2018-01104","article-title":"Primary Hyperparathyroidism in Pregnancy: Maternofetal Outcomes at a Quaternary Referral Obstetric Hospital, 2000 Through 2015","volume":"10","author":"Rigg","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0280","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/js.2017-00308","article-title":"Use of Cinacalcet and 99mTc-sestamibi Imaging during pregnancy","author":"Rubin","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jbspin.2021.105129_bib0285","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/js.2018-00340","article-title":"Seventeen cases of primary hyperparathyroidism in pregnancy: a call for management guidelines","volume":"3","author":"DiMarco","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jbspin.2021.105129_bib0290","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1634\/theoncologist.2011-0285","article-title":"What is the utility of distal forearm DXA in primary hyperparathyroidism?","volume":"17","author":"Wood","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.jbspin.2021.105129_bib0295","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0300","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jbspin.2021.105129_bib0305","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/jc.2008-1761","article-title":"Surgery for asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop J","volume":"94","author":"Udelsman","year":"2009","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0310","doi-asserted-by":"crossref","first-page":"E2159","DOI":"10.1002\/hed.24027","article-title":"Detection rate of (99 m) Tc-MIBI single photon emission computed tomography (SPECT)\/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis","volume":"38","author":"Treglia","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.jbspin.2021.105129_bib0315","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary Hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2021.105129_bib0320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13550-019-0544-3","article-title":"Parathyroid imaging with 18F-fluorocholine PET\/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study","volume":"9","author":"Broos","year":"2019","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jbspin.2021.105129_bib0325","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoto.2019.0574","article-title":"Usefulness of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in Locating Lesions in Hyperparathyroidism: A Systematic Review","author":"Boccalatte","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jbspin.2021.105129_bib0330","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00259-017-3911-1","article-title":"F18-choline PET\/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT\/CT are negative or inconclusive: the APACH1 study","volume":"45","author":"Quak","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jbspin.2021.105129_bib0335","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40618-018-0931-z","article-title":"PETC\/CT with 18F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism","volume":"42","author":"Bossert","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jbspin.2021.105129_bib0340","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0003489419876291","article-title":"A practical mathematic method to predict and manage hypocalcemia after parathyroidectomy and thyroidectomy","volume":"129","author":"Liu","year":"2020","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jbspin.2021.105129_bib0345","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of the Fourth International Workshop","volume":"99","author":"Udelsman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0350","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1210\/jc.2019-00705","article-title":"Persistently elevated PTH after parathyroidectomy at one year: experience in a tertiary referral center","volume":"104","author":"Caldwell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0355","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2014-4548","article-title":"Hypercalciuria May Persist After Successful Parathyroid Surgery and It Is Associated with Parathyroid Hyperplasia","volume":"100","author":"Palmieri","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.jbspin.2021.105129_bib0360","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.beem.2018.09.006","article-title":"Non-surgical management of primary hyperparathyroidism","volume":"32","author":"Cetani","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0365","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4158\/EP08178.ORR","article-title":"Alendronate therapy in men with primary hyperparathyroidism","volume":"15","author":"Khan","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jbspin.2021.105129_bib0370","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1055\/s-0033-1349842","article-title":"Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate","volume":"45","author":"Szymczak","year":"2013","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jbspin.2021.105129_bib0375","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.surg.2019.04.059","article-title":"Skeletal effects of combined medical and surgical management of primary hyperparathyroidism","volume":"167","author":"Orr","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.jbspin.2021.105129_bib0380","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2021.105129_bib0385","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/M15-1232","article-title":"The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism: An Observational Study","volume":"164","author":"Yeh","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2021.105129_bib0390","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bone.2018.12.012","article-title":"Acute hypercalcemia and excessive bone resorption following anti-RANKL withdrawal: Case report and brief literature review","volume":"120","author":"Roux","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2021.105129_bib0395","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-011-9459-0","article-title":"Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism","volume":"39","author":"Faggiano","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.jbspin.2021.105129_bib0400","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X21000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X21000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:29:26Z","timestamp":1761150566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X21000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1297319X21000014"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2021.105129","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone and primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2021.105129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"105129"}}